Introduction {#Sec1}
============

For some decades, mathematical models have been used in biological sciences to understand diverse aspects of *diabetes mellitus* (DM)^[@CR1]^. For example, DM progression^[@CR2],[@CR3]^, diagnostic test evaluations^[@CR4],[@CR5]^, long-term micro and macrovascular complications^[@CR6],[@CR7]^, and blood glucose dynamics^[@CR8]--[@CR10]^, among others, have been modeled. Particularly, mathematical models to emulate blood glucose dynamics in DM have been classified, according to the complexity of their description, in two major groups^[@CR11]^. The first group considers the whole-body models developed under a pharmacokinetic--pharmacodynamic (PKPD) approach, which is characterized by being structurally simple with a limited physiological interpretation. The second group considers the physiological based PKPD (PB-PKPD) models, which mathematically describe the physiological interactions between different subsystems of the human body. Due to its structural simplicity, most of the models in the literature are PKPD^[@CR1]^. Although these models are widely used, they do not include most of the processes responsible for glucose homeostasis. Hence, its use to model complex processes in DM, such as the DM pathophysiology, is limited and, it induces a trend toward the development of PB-PKPD models^[@CR1]^. These models have focused on emulating the metabolic processes involved in glucose homeostasis, and are usually organ-based. Moreover, the PB-PKPD models of blood glucose dynamics in type 1 DM (T1DM) have been useful to synthesize model-based controllers for blood glucose regulation in T1DM^[@CR12]--[@CR16]^. However, type 2 DM (T2DM) affects multiple subsystems of the body and, consequently, the mathematical representation of the metabolic abnormalities in T2DM is challenging^[@CR17]^.

One of the most widely used PB-PKPD models was performed by Sorensen^[@CR10]^. This organ-based compartmental model emulates the blood glucose dynamics of a healthy human by considering the main glucose metabolic rates as mathematical functions. In this model, each mathematical function was individually fitted to a set of clinical data of healthy people where the metabolic response of the patients was measured for different stimuli. Then, the physiology of the main metabolic rates of a healthy human body was mathematically reproduced. Although Sorensen's model is quite robust, it has some limitations. For instance, the model does not include blood glucose and insulin dynamics in the pancreas. Instead, a single function representing the pancreatic insulin release rate is connected to the bloodstream. The above does not represent the physiology of the human body. In addition, the model does not consider the effect of gastric emptying. Therefore, the blood glucose dynamics after oral glucose intake, and the potentiating-insulin effect of the incretin hormones cannot be reproduced.

An extension of the Sorensen's model, which covers its main limitations, was proposed by Alverhag and Martin^[@CR9]^. Thus, the model included two ordinary differential equations (ODE) to quantify, through mass balance, the time-variation of the blood glucose and insulin in the pancreas. Additionally, the gastric emptying process, and the enhancing effect on insulin due to the incretin hormones were included by considering two new subsystem attached to the model. Furthermore, Alverhag and Martin hypothesize that a model of the blood glucose dynamics in T2DM can be developed by identifying the parameters of the mathematical functions representing the metabolic rates related to the pathophysiology of this condition^[@CR9]^. Based on the above, Vahidi et al. used a nonlinear optimization approach to identify some parameters of the Sorensen's model from a single data set of an oral glucose tolerance test (OGTT) in T2DM patients^[@CR8]^. Even though in this article, the system response acceptably reproduces the OGTT, the set of identified parameters that minimize the error between clinical data and the system may not be unique. Therefore, it cannot be assured that the metabolic functions containing the identified parameters emulate the pathophysiology of the T2DM individually.

Consequently, this article proposes a PB-PKPD model of the blood glucose dynamics in T2DM, where some mathematical functions representing metabolic rates of the body, are individually fit to emulate the pathophysiology of the T2DM. Moreover, the effect of the gastric emptying, and the enhancing effect of insulin due to the incretin hormones are included to reproduce the blood glucose dynamics after oral glucose intake. To achieve this, the mathematical model of the blood glucose dynamics in a healthy human body, proposed in Alvehag and Martin^[@CR9]^, will be described as a set of 28-dimensional ODE. From the ODE set, the mathematical functions representing the impaired metabolic rates in T2DM were individually fitted to clinical data of T2DM patients by using the least-squares method (LSM). The clinical data were taken from several clinical tests where direct measurements of the tissues or organ response to local changes in solutes concentration were made. The resulting model was numerically simulated to test its ability to reproduce the blood glucose dynamic in T2DM patients for different inputs, and initial conditions. Finally, the error between the simulation, and the clinical data of the T2DM patients is quantified by using a statistical function.

This manuscript is organized as follows: "[Methodology](#Sec2){ref-type="sec"}\" shows the methodology, while the results and discussions are set out in "[Results and discussion](#Sec8){ref-type="sec"}". Finally, the article ends with some concluding observations on this work in "[Concluding remarks](#Sec9){ref-type="sec"}". Also, [Supplementary information](#MOESM1){ref-type="media"} have been included to show the nomenclature of all the variables and the numerical values of the parameters contained in the equations used throughout the manuscript.

Methodology {#Sec2}
===========

The mathematical model in Alverhag y Martin is a nonlinear dynamic system consisting of four clustered subsystems^[@CR9]^. The subsystems are compartmental representations of the human body, where each compartment represents an organ or tissue where an important process of mass exchange is carried out. The compartments are interconnected through the blood flow. Then, by means of a mass balance in the compartments, each of the subsystems quantifies the concentration of one solute (i.e., glucose, insulin, glucagon, or incretins). A detailed explanation of the system and its nomenclature can be found the [Supplementary information](#MOESM1){ref-type="media"}.

The system is a set of 28 ODEs composed of nonlinear continuous functions. Therefore, it follows that the solution of the system (*x*(*t*)) exists in a domain $\documentclass[12pt]{minimal}
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                \begin{document}$$\subset \mathbb {R}^{67}$$\end{document}$ contains the parameters in the functions representing the metabolic rates of the system. The parameter values of the system in Eq. ([2](#Equ2){ref-type=""}) can be found in the [Supplementary information](#MOESM1){ref-type="media"}.

Model simulation and initialization {#Sec3}
-----------------------------------

The mathematical model in Eq. ([2](#Equ2){ref-type=""}) successfully simulates the blood glucose dynamics of a healthy human body after intravenous glucose infusion and oral glucose intake^[@CR9]^. For the above, an input to the system is considered containing: (i) a continuous intravenous glucose infusion rate ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{14}=I_{PV}$$\end{document}$, whose meaning concerns to glucose and insulin vascular concentration in peripheral tissues, respectively. The time evolution of *y* is used to compare the model simulation with clinical data where the glucose and insulin concentrations are taken from a blood sample of the patient's forearm during a test. For all the simulations, the model in Eq. ([2](#Equ2){ref-type=""}) was numerically solved by using a variable step in the function *ode45 (Dormand-Prince)* of MATLAB^[@CR18]^. The simulation time was defined as the time length of the clinical trial.
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Metabolic rates of the model {#Sec4}
----------------------------

The subsystems described in the [Supplementary information](#MOESM1){ref-type="media"} are coupled by the functions representing the metabolic rates of the glucose, insulin, glucagon, and incretins. These metabolic rates are mathematically modeled as constant or linear functions of the mass accumulation in the compartments; or multiplicative functions of the metabolic basal rate. Specifically, the metabolic rates in the glucose, and glucagon subsystems are multiplicative functions with the following general form:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\eta $$\end{document}$ parameters can be found in the [Supplementary information](#MOESM1){ref-type="media"}. Using these values, the system in Eq. ([2](#Equ2){ref-type=""}) simulates the blood glucose dynamics after an intravenous glucose infusion or an oral glucose intake in a healthy human body^[@CR9]^. For the mathematical modelling of the blood glucose dynamics of T2DM, the pathophysiology of T2DM must be emulated by modifying the value of the parameters of the functions representing the metabolic rates responsible of the characteristic hyperglycaemia. The above will be described in "[Curve fitting](#Sec5){ref-type="sec"}".

Curve fitting {#Sec5}
-------------

For decades, different studies have identified the metabolic problems associated with the progression of T2DM in healthy humans^[@CR19],[@CR20]^. It has been found that these problems are related to the metabolism of fats, and carbohydrates^[@CR19],[@CR20]^. The metabolism of this latter is the object of study in this work.

Mainly, the pathophysiology of the T2DM is characterized by^[@CR19]^: (i) insulin resistance, defined as an impaired effect of insulin on glucose uptake by peripheral tissues, (ii) excessive hepatic glucose production, due to accelerated gluconeogenesis, and (iii) $\documentclass[12pt]{minimal}
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In what it follows, the sensitive metabolic rates were selected to fit the clinical data of T2DM patients. Explicitly, the fitting of $\documentclass[12pt]{minimal}
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### Static and dynamic fitting approach {#Sec6}

To solve the parameter fitting problem, two things are required: A set of clinical data in T2DM patients.A mathematical method to fit such data to the function representing the sensitive metabolic rates.The set of clinical data used for the isolated effects fitting was obtained from selected clinical tests of T2DM patients. The conditions of each one of the selected articles are consistent with those originally considered for mathematical modeling in Ref.^[@CR10]^. These conditions are compiled in Table [1](#Tab1){ref-type="table"}. In the selected articles, the clinical data was taken from a set $\documentclass[12pt]{minimal}
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                \begin{document}$$r_{PIR}$$\end{document}$, Grodsky obtained data from a graded glucose step-response with the isolated perfused pancreas in rats^[@CR25]^. Since it is impossible to obtain this data from humans, the selected parameters of this metabolic rate were identified using clinical data from an input--output approach of the system, in Eq. ([2](#Equ2){ref-type=""}). The data were taken from an OGTT in DeFronzo et al.^[@CR26]^, where the plasma glucose and insulin response to oral intake were measured in nine T2DM subjects after the consumption of 1 g/kg-body weight of oral glucose.Table 1Conditions of the clinical test and its interpretation in the mathematical model.RateConditions$\documentclass[12pt]{minimal}
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                \begin{document}$$M_{HGP}^G$$\end{document}$Somatostatin was administered to block the endogenous release of insulin, and glucagon. Exogenous insulin, and glucagon replacements were introduced to the patients to maintain them in their basal state (i.e., $\documentclass[12pt]{minimal}
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The mathematical method used to fit the functions to clinical data is the least squares (LSM). In general, the LSM lies that the following relation is fulfilled^[@CR27]^:$$\documentclass[12pt]{minimal}
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In the static approach, the unknown parameters from the Eq. ([5](#Equ5){ref-type=""}) are grouped as $\documentclass[12pt]{minimal}
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                \begin{document}$$z_k$$\end{document}$ is the clinical data of the mean of the normalized solute concentration taken from the forearm. The minimization of the objective function in Eq. ([7](#Equ7){ref-type=""}) was numerically solved with the function *lsqcurvefit* of the optimization toolbox of MATLAB^[@CR18]^. The iterative algorithm used to find $\documentclass[12pt]{minimal}
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In the dynamical approach the selected parameters from $\documentclass[12pt]{minimal}
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                \begin{document}$$y_{2k}$$\end{document}$ are the clinical data obtained from the mean of glucose and insulin concentrations, respectively, taken at the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$z_k$$\end{document}$ time, the weights $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$w_1$$\end{document}$ and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$w_2$$\end{document}$ are the mean of the basal glucose, and insulin concentrations, respectively; and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$f_1=x_6(z_k,\theta )$$\end{document}$, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$f_2=x_{14}(z_k,\theta )$$\end{document}$ were obtained from the model simulation. The above clinical data was taken from DeFronzo et al.^[@CR26]^. The LSM problem in Eq. ([8](#Equ8){ref-type=""}) was numerically solved using the function *fmincon* of the optimization toolbox of MATLAB^[@CR18]^ with the iterative algorithm 'interior-point'. After the identification of the parameters of $\documentclass[12pt]{minimal}
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                \begin{document}$$\hat{\theta }$$\end{document}$ in order to emulate the pathophysiology of T2DM. Hereinafter, the resulting model is called *T2DM model*.

Comparison of the T2DM model with clinical data {#Sec7}
-----------------------------------------------

The T2DM model was numerically simulated for comparison with a clinical test in T2DM where the blood glucose dynamics is observed after different stimuli. Considering that the route of glucose entry into the body plays an essential role overall glucose homeostasis^[@CR26]^, the T2DM model was simulated for the following test: (i) a programmed graded intravenous glucose infusion test (PGIGI) to account for the rapid response of the intravenous infusions, and (ii) an OGTT considering a dose of 50 g of glucose (50 g-OGTT), and a dose of 75 g of glucose (75 g-OGTT) to account for blood glucose changes due to the gastric emptying process, and the effects of the incretin.

The clinical data used to compare the DMT2 model with a PGIGI test was obtained from Carperntier et al.^[@CR29]^. In this test, the glucose was administered intravenously in a total of 7 subjects with DMT2 (i.e., $\documentclass[12pt]{minimal}
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                \begin{document}$$^{-1}$$\end{document}$ for a period of 40 min each one. The conditions for model simulation were $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$G_{PV}^B=G_{PV}(0)=157.5$$\end{document}$ mg dL$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$^{-1}$$\end{document}$, and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$I_ {PV}^B=I_{PV}(0)=13.02$$\end{document}$ mU $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\hbox {L}^{-1}$$\end{document}$.

The clinical data used to compare the DMT2 model with an OGTT was obtained from Firth et al.^[@CR30]^, and Mari et al.^[@CR31]^. In these test, 50 and 75 g of oral glucose was consumed by a total of 13 and 46 subjects with DMT2, respectively (i.e., $\documentclass[12pt]{minimal}
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Results and discussion {#Sec8}
======================
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The characteristic hepatic insulin resistance of the T2DM is evident in Fig. [1](#Fig1){ref-type="fig"}b,c. This can be observed in the behavior of the curves for high values of the solute concentration, where the hepatic glucose production can not be suppressed entirely despite significant increment of the normalized glucose and insulin concentration in the liver. The above is consistent with clinical evidence where the blood glucose has an impaired ability to inhibit the hepatic glucose production at basal insulin and glucagon concentrations in T2DM^[@CR19],[@CR36],[@CR37]^; and the insulin concentration is ineffective to suppress the hepatic glucose production at basal glucose and glucagon concentrations in T2DM^[@CR26],[@CR38]--[@CR40]^. Finally, the role of glucagon in hepatic glucose production in T2DM patients can be seen in Fig. [1](#Fig1){ref-type="fig"}d. In this graphical representation, the behavior of the function $\documentclass[12pt]{minimal}
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Once the nominal values of the parameters are replaced by those in $\documentclass[12pt]{minimal}
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As noted in "[Methodology](#Sec2){ref-type="sec"}\", since there is no clinical data of the individual response of $\documentclass[12pt]{minimal}
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                \begin{document}$$r_{PIR}$$\end{document}$ is based on nonlinear optimization. As a result, the set of values obtained minimizes the objective function of the Eq. ([8](#Equ8){ref-type=""}), nevertheless, it cannot be assured that the pathophysiology of the pancreatic insulin secretion in T2DM is individually emulated. However, due to the individual fitting of the isolated effects, the number of parameters to be identified by a dynamic approach is minimal. A proposal to avoid the above is to replace the pancreatic insulin subsystem with a model of the pancreas whose pathophysiology could be described by a set of clinical data of patients with DMT2.Figure 2Graphical result of $\documentclass[12pt]{minimal}
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After the metabolic rates fitting the resulting model (i.e., T2DM model) was simulated and compared with clinical data. In Fig. [3](#Fig3){ref-type="fig"}, it can be seen the T2DM model response for the PGIGI test, and the clinical data from Carpentier et al.^[@CR29]^. As can be seen, the simulation of the T2DM model is not significantly different from the reported clinical data. Moreover, the absolute of the maximum difference between simulation, and the clinical data is 9.4 mg dL$\documentclass[12pt]{minimal}
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                \begin{document}$$^{-1}$$\end{document}$ for this test. It follows that the T2DM model can reproduce the step response of the blood glucose due to an intravenous glucose infusion input.Figure 3Simulation of a PGIGI test. In this plot the solid line represents the simulation of the blood glucose in the peripheral compartment of the T2DM model. The symbols represent the mean±SEM value of solute from the $\documentclass[12pt]{minimal}
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Figure [4](#Fig4){ref-type="fig"} shows the T2DM model response of the OGTT for different doses. Similarly to the observed clinical data, the model response $\documentclass[12pt]{minimal}
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                \begin{document}$$^{-1}$$\end{document}$, respectively. As can be seen, after oral glucose intake, the response of the model for the OGTT test is relatively slow, showing a maximum peak at approximately 80 min after glucose stimulation. Compared with the results of the PGIGI, the increase in glycaemia in the OGTT is slower. This is because of the digestion process, after an oral glucose intake, induces a delay proportional to the glucose appearance rate in the gut. Furthermore, as can be seen in Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} the basal blood glucose is slightly elevated compared to the concentration of a healthy subject.Figure 4Simulation of 25 g and 75 g-OGTT. In this plot the solid and dashed lines represent the simulation of the blood glucose in the peripheral compartment of the T2DM model during a 25 g and 75 g-OGTT, respectively. The symbols represent the mean value of solute from the n subjects. Particularly, the triangles represent the mean ±SEM. The data for the 25 g and 75 g-OGTT were taken from Mari et al., and Firth et al., respectively.

According to the World Health Organization guidance for diagnostic tests of DM, a fasting glucose concentration $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\ge $$\end{document}$126 mg dL$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$^{-1}$$\end{document}$ is characteristic of DM^[@CR43]^. Moreover, the patients with this impaired blood glucose should undergo by a formal 75 g-OGTT for DM diagnosis^[@CR43]^. A representation of this test can be seen in Fig. [4](#Fig4){ref-type="fig"} where after two-hour postload glucose the dotted curve had shown a glucose concentration $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\ge $$\end{document}$140 mg dL$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$^{-1}$$\end{document}$. This is a characteristic behavior of DMT2 that contrasts with that of a healthy subject, where the normal homeostatic glucose process results in a concentration of less than 140 mg dL$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$^{-1}$$\end{document}$ after 2 h of the glucose intake.
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                \begin{document}$$\sigma $$\end{document}$ function, it can be concluded that the model emulates with acceptable precision what is reported in the clinical data for PGIGI, and OGTT. However, this model considers only the carbohydrate metabolism but not fat, and protein metabolism. Therefore, the effect of free fatty acids, and the physiology related to amino acids level on blood glucose dynamics are not included. Besides, the model does not consider the counter-regulatory effect of growth hormones, adrenaline, or cortisol. Nevertheless, the above can be considered later in the model by adding other subsystems for the free fatty acids dynamics, and other metabolic functions to consider the effect of the missing hormones.
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The main contribution of this article was derivating a model for T2DM, including physiological features to emulate blood glucose dynamics. The modelling departs from a PB-PKPD modelling approach, and the individual fitting of the sensitive metabolic rates allows us to capture the pathophysiology of the metabolic rates in T2DM. This methodological procedure enables us to successfully emulate the blood glucose dynamics of T2DM after a continuous intravenous glucose infusion an oral glucose intake. As convincing numerical evidence of the above, Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} show to what extent the T2DM model predicts the clinical data.

The individual fitting of the sensitive metabolic rates to clinical data ensures that the pathophysiology of T2DM is preserved, such that diverse scenarios might be predicted. For instance, this model can be used to determine appropriate oral therapy for blood glucose regulation by connecting a PKPD model of a hypoglycaemic drug (e.g., sulfonylureas, biguanides, thiazolidinediones, among others). Such is the case of metformin therapy, where the target metabolic rates were modified by adding a multiplicative factor in $\documentclass[12pt]{minimal}
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